TCL Archive Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable January 31, 2003
TCL Archive In Brief: GAO Probe Of Cancer Control Program Nears End; Renewal Bill Mark Up Not Before Oct. 22 October 12, 1979